The 3D scaffold bioprinting experiments for the ISOLPHARM project started at the beginning of 2024 with some geometry printing tests, where GelMa was cured under a DLP homemade printer with the main task of testing the printing resolution of the instrument. At the end of October the first test where the ink was a mixture…
Read more
In October 2024, the ISOLPHARM collaboration successfully performed the first clonogenic survival evaluation using silver-111 on cancer cells. In particular, the UMR-106 rat osteosarcoma cell line was tested. This result represents a first important experimental milestone reached by the ISOLPHARM radiobiology community, which includes groups from the Universities of Pavia (with the LENA facility), Padova,…
Read more
At the CAPiR lab of Catania a solution containing Ag-111 was injected in mice. The Bruker In-Vivo Xtreme was then used to acquire digital autoradiography images after several time points. This is the first time in which the collaboration acquires in-vivo images through the Ag-111 radiation.
